Literature DB >> 29523921

Impact of Hybrid Stage 1 Palliation for Hypoplastic Left Heart Syndrome: Histopathological Findings.

Takashi Kido1, Takaya Hoashi2, Masataka Kitano3, Masatoshi Shimada1, Kenichi Kurosaki3, Hatsue Ishibashi-Ueda4, Hajime Ichikawa1.   

Abstract

The purpose of the study is to analyze the impact of hybrid stage 1 palliation on right ventricular myocardial pathology in hypoplastic left heart syndrome. Sufficient amount of right ventricular biopsies could be obtained from 16 of 32 patients who underwent Norwood operation between 2007 and 2013. Histopathological findings of right ventricle in patients who underwent primary Norwood operation (primary group, n = 5), patients with aortic atresia (HS1P AA group, n = 6) or aortic stenosis (HS1P AS group, n = 5) who underwent staged Norwood palliation following hybrid stage 1 palliation were compared. To eliminate the influence of right ventricular pressure afterload, right ventricular biopsies were obtained from patients with truncus arteriosus communis (TAC group, n = 6) at total correction. The percentage of myocardial fibrosis was significantly higher in both HS1P groups than in TAC group; moreover, it was significantly higher in HS1P AA group than in primary group. Capillary vascular density was significantly lower in all hypoplastic left heart syndrome groups than in TAC group. At the sub-endocardial layer, collagen type I/III ratios were higher in HS1P AA group than in other hypoplastic left heart syndrome groups. The proportions of N-cadherin immunolocalized to myocyte termini were lower in all hypoplastic left heart syndrome groups than in TAC group. Right ventricle in hypoplastic left heart syndrome showed more significant ischemic change and myocardial immaturity than that in truncus arteriosus communis. Hybrid stage 1 palliation for aortic atresia would be a risk factor for further right ventricular myocardial ischemia.

Entities:  

Keywords:  Hybrid stage 1 palliation; Hypoplastic left heart syndrome; Right ventricular myocardium

Mesh:

Year:  2018        PMID: 29523921     DOI: 10.1007/s00246-018-1851-6

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  28 in total

1.  Disturbed myocardial connexin 43 and N-cadherin expressions in hypoplastic left heart syndrome and borderline left ventricle.

Authors:  Edris A F Mahtab; Adriana C Gittenberger-de Groot; Rebecca Vicente-Steijn; Heleen Lie-Venema; Marry E B Rijlaarsdam; Mark G Hazekamp; Margot M Bartelings
Journal:  J Thorac Cardiovasc Surg       Date:  2012-03-08       Impact factor: 5.209

2.  Risk factors for hospital morbidity and mortality after the Norwood procedure: A report from the Pediatric Heart Network Single Ventricle Reconstruction trial.

Authors:  Sarah Tabbutt; Nancy Ghanayem; Chitra Ravishankar; Lynn A Sleeper; David S Cooper; Deborah U Frank; Minmin Lu; Christian Pizarro; Peter Frommelt; Caren S Goldberg; Eric M Graham; Catherine Dent Krawczeski; Wyman W Lai; Alan Lewis; Joel A Kirsh; Lynn Mahony; Richard G Ohye; Janet Simsic; Andrew J Lodge; Ellen Spurrier; Mario Stylianou; Peter Laussen
Journal:  J Thorac Cardiovasc Surg       Date:  2012-06-15       Impact factor: 5.209

3.  Impact of Patient Characteristics and Anatomy on Results of Norwood Operation for Hypoplastic Left Heart Syndrome.

Authors:  Bahaaldin Alsoufi; Makoto Mori; Scott Gillespie; Brian Schlosser; Timothy Slesnick; Brian Kogon; Dennis Kim; Ritu Sachdeva; Kirk Kanter
Journal:  Ann Thorac Surg       Date:  2015-06-30       Impact factor: 4.330

4.  Long-Term Results of Bilateral Pulmonary Artery Banding Versus Primary Norwood Procedure.

Authors:  Yasutaka Hirata; Hiroaki Miyata; Norimichi Hirahara; Arata Murakami; Hideaki Kado; Kisaburo Sakamoto; Shunji Sano; Shinichi Takamoto
Journal:  Pediatr Cardiol       Date:  2017-09-21       Impact factor: 1.655

5.  Improved outcomes with the comprehensive stage 2 procedure after an initial hybrid stage 1.

Authors:  Mark Galantowicz; Andrew R Yates
Journal:  J Thorac Cardiovasc Surg       Date:  2015-10-23       Impact factor: 5.209

Review 6.  The myocardial and coronary histopathology and pathogenesis of hypoplastic left heart syndrome.

Authors:  Charles R Cole; Pirooz Eghtesady
Journal:  Cardiol Young       Date:  2015-07-08       Impact factor: 1.093

7.  The retrograde aortic arch in the hybrid approach to hypoplastic left heart syndrome.

Authors:  Serban C Stoica; Alistair B Philips; Matthew Egan; Roberta Rodeman; Joanne Chisolm; Sharon Hill; John P Cheatham; Mark E Galantowicz
Journal:  Ann Thorac Surg       Date:  2009-12       Impact factor: 4.330

8.  Survival and right ventricular performance for matched children after stage-1 Norwood: Modified Blalock-Taussig shunt versus right-ventricle-to-pulmonary-artery conduit.

Authors:  Travis J Wilder; Brian W McCrindle; Alistair B Phillips; Eugene H Blackstone; Jeevanantham Rajeswaran; William G Williams; William M DeCampli; Jeffrey P Jacobs; Marshall L Jacobs; Tara Karamlou; Paul M Kirshbom; Gary K Lofland; Gerhard Ziemer; Edward J Hickey
Journal:  J Thorac Cardiovasc Surg       Date:  2015-07-02       Impact factor: 5.209

9.  Morphometry of coronary capillaries in hypoplastic left heart syndrome.

Authors:  Caner Salih; Mary N Sheppard; Siew Yen Ho
Journal:  Ann Thorac Surg       Date:  2004-03       Impact factor: 4.330

10.  Hybrid therapy for hypoplastic left heart syndrome: Myth, alternative, or standard?

Authors:  Can Yerebakan; Klaus Valeske; Hatem Elmontaser; Uygar Yörüker; Matthias Mueller; Josef Thul; Valesco Mann; Heiner Latus; Anika Villanueva; Karoline Hofmann; Dietmar Schranz; Hakan Akintuerk
Journal:  J Thorac Cardiovasc Surg       Date:  2015-10-27       Impact factor: 5.209

View more
  1 in total

1.  Single-Cell RNA Sequencing and Quantitative Proteomics Analysis Elucidate Marker Genes and Molecular Mechanisms in Hypoplastic Left Heart Patients With Heart Failure.

Authors:  Li Ma; Na Zhou; Rongjun Zou; Wanting Shi; Yuanyuan Luo; Na Du; Jing Zhong; Xiaodong Zhao; Xinxin Chen; Huimin Xia; Yueheng Wu
Journal:  Front Cell Dev Biol       Date:  2021-02-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.